All Stories

  1. Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients

    Article • Antimicrobial Agents and Chemotherapy, January 2018, ASM Journals

    Marc Scheetz

  2. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Marc Scheetz

  3. A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization

    Article • Infection Control, May 2017, Cambridge University Press

    Marc Scheetz

  4. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  5. Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  6. Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse

    Article • Antimicrobial Agents and Chemotherapy, November 2015, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  7. Unacceptably High Error Rates in Vitek 2 Testing of Cefepime Susceptibility in Extended-Spectrum-β-Lactamase-Producing Escherichia coli

    Article • Antimicrobial Agents and Chemotherapy, April 2014, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  8. Impact of vancomycin treatment duration and dose on kidney injury

    Article • International Journal of Antimicrobial Agents, March 2014, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  9. Novel Work Models Needed for Faculty Members Trying to Balance Clinical Practice With Scholarly Responsibilities

    Article • American Journal of Pharmaceutical Education, February 2014, American Journal of Pharmaceutical Education

    Marc Scheetz, Dr Marc H. Scheetz

  10. Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study to translate to patient outcomes

    Article • BMC Infectious Diseases, January 2014, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  11. Pathogenicity of Clinical Acinetobacter baumannii Isolates in a Galleria mellonella Host Model According toblaOXA-40Gene and Epidemiological Outbreak Status

    Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  12. Characterization of Ciprofloxacin Resistant Escherichia coli Isolates among Men Undergoing Evaluation for Transrectal Ultrasound Guided Prostate Biopsy

    Article • The Journal of Urology, December 2013, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  13. Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High-Flux Hemodialysis

    Article • Antimicrobial Agents and Chemotherapy, September 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  14. Empty Shelves, Full of Frustration: Consequences of Drug Shortages and the Need for Action

    Article • Hospital Pharmacy, September 2013, Thomas Land Publishers

    Marc Scheetz, Dr Marc H. Scheetz

  15. Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2013, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  16. Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  17. Virulence of Vancomycin-Resistant Enterococcus faecium According to Linezolid Resistance and Clinical Outbreak Status

    Article • Antimicrobial Agents and Chemotherapy, June 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  18. Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

    Article • Drug Safety, April 2013, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  19. Temporal changes in pulsed-field gel electrophoresis banding in vancomycin-resistant Enterococcus faecium and implications for outbreak investigations

    Article • American Journal of Infection Control, April 2013, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  20. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique

    Article • Clinical Transplantation, October 2012, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  21. An Analysis of the Accuracy of Physician-Entered Indications on Computerized Antimicrobial Orders

    Article • Infection Control, October 2012, Cambridge University Press

    Marc Scheetz, Dr Marc H. Scheetz

  22. Prospective Approach to Managing Antimicrobial Drug Shortages

    Article • Infection Control, July 2012, Cambridge University Press

    Marc Scheetz, Dr Marc H. Scheetz

  23. Antimicrobial Drug Shortages: A Crisis Amidst the Epidemic and the Need for Antimicrobial Stewardship Efforts to Lessen the Effects

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2012, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  24. Targeted Antimicrobial Prophylaxis Using Rectal Swab Cultures in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy is Associated With Reduced Incidence of Postoperative Infectious Complications and Cost of Care

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  25. Antimicrobial stewardship programs: methods of operation and suggested outcomes

    Article • Expert Review of Anti-infective Therapy, January 2012, Informa Healthcare

    Marc Scheetz, Dr Marc H. Scheetz

  26. Life-Years Gained with Meropenem over Ciprofloxacin in Penicillin-Allergic Patients with Gram-Negative Bacilli Sepsis: Results of a Probabilistic Model

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2011, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  27. Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practice

    Article • International Journal of Clinical Pharmacy, March 2011, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  28. Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity

    Article • International Journal of Nephrology, January 2011, Hindawi Publishing Corporation

    Marc Scheetz, Dr Marc H. Scheetz

  29. Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2010, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  30. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

    Article • Clinical Therapeutics, September 2010, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  31. The Impact of Qualitative Respiratory Cultures on Mortality in Critically Ill Patients With Hospital-Acquired Pneumonia

    Article • Hospital Pharmacy, August 2010, Thomas Land Publishers

    Marc Scheetz, Dr Marc H. Scheetz

  32. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients

    Article • International Journal of Antimicrobial Agents, July 2010, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  33. Predictability of Doripenem Susceptibility in Acinetobacter baumannii Isolates Based on Other Carbapenem Susceptibilities and bla OXA Gene Status

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2010, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  34. The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock

    Article • American Journal of Therapeutics, November 2009, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  35. Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection

    Article • Diagnostic Microbiology and Infectious Disease, September 2009, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  36. Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa

    Article • Diagnostic Microbiology and Infectious Disease, August 2009, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  37. Morbidity associated with Pseudomonas aeruginosa bloodstream infections

    Article • Diagnostic Microbiology and Infectious Disease, July 2009, Elsevier

    Marc Scheetz, Dr Alan R Hauser, Dr Marc H. Scheetz

  38. Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use

    Article • Drug Safety, January 2009, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  39. Leukopenia Complicates Cytomegalovirus Prevention After Renal Transplantation With Alemtuzumab Induction

    Article • Transplantation, April 2007, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  40. Systematic Review of Piperacillin-Induced Neutropenia

    Article • Drug Safety, January 2007, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  41. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci

    Article • Diagnostic Microbiology and Infectious Disease, December 2006, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  42. Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2006, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  43. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia

    Article • Journal of Infection, February 2006, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz